BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28608326)

  • 1. Identification of myocardial diffuse fibrosis by 11 heartbeat MOLLI T
    Vassiliou VS; Wassilew K; Cameron D; Heng EL; Nyktari E; Asimakopoulos G; de Souza A; Giri S; Pierce I; Jabbour A; Firmin D; Frenneaux M; Gatehouse P; Pennell DJ; Prasad SK
    MAGMA; 2018 Feb; 31(1):101-113. PubMed ID: 28608326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
    de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis.
    Backhaus SJ; Lange T; Beuthner BE; Topci R; Wang X; Kowallick JT; Lotz J; Seidler T; Toischer K; Zeisberg EM; Puls M; Jacobshagen C; Uecker M; Hasenfuß G; Schuster A
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):46. PubMed ID: 32564773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements.
    Hong K; Kim D
    NMR Biomed; 2014 Nov; 27(11):1419-26. PubMed ID: 25323070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized AIR and investigational MOLLI cardiac T1 mapping pulse sequences produce similar intra-scan repeatability in patients at 3T.
    Hong K; Collins J; Lee DC; Wilcox JE; Markl M; Carr J; Kim D
    NMR Biomed; 2016 Oct; 29(10):1454-63. PubMed ID: 27593977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
    Fontana M; White SK; Banypersad SM; Sado DM; Maestrini V; Flett AS; Piechnik SK; Neubauer S; Roberts N; Moon JC
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):88. PubMed ID: 23272651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of myocardial magnetic resonance extracellular volume mapping at 3 T against histology of tissue collagen in severe aortic valve stenosis and obstructive hypertrophic cardiomyopathy.
    Bakermans AJ; Kouwenhoven M; de Vos J; de Vries DK; Reckman YJ; Farag ES; Koolbergen DR; Kluin J; Nederveen AJ; Strijkers GJ; Boekholdt SM
    MAGMA; 2023 Oct; 36(5):701-709. PubMed ID: 36820958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance T1 and extracellular volume mapping with motion correction and co-registration based on fast elastic image registration.
    Zhang S; Le TT; Kabus S; Su B; Hausenloy DJ; Cook SA; Chin CWL; Tan RS
    MAGMA; 2018 Feb; 31(1):115-129. PubMed ID: 29270904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac stress T1-mapping response and extracellular volume stability of MOLLI-based T1-mapping methods.
    Burrage MK; Shanmuganathan M; Zhang Q; Hann E; Popescu IA; Soundarajan R; Chow K; Neubauer S; Ferreira VM; Piechnik SK
    Sci Rep; 2021 Jun; 11(1):13568. PubMed ID: 34193894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.
    Miller CA; Naish JH; Bishop P; Coutts G; Clark D; Zhao S; Ray SG; Yonan N; Williams SG; Flett AS; Moon JC; Greiser A; Parker GJ; Schmitt M
    Circ Cardiovasc Imaging; 2013 May; 6(3):373-83. PubMed ID: 23553570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
    Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
    Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation.
    Zhao L; Li S; Ma X; Greiser A; Zhang T; An J; Bai R; Dong J; Fan Z
    J Cardiovasc Magn Reson; 2016 Mar; 18():13. PubMed ID: 26980571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.
    Li F; Xu M; Fan Y; Wang Y; Song Y; Cui X; Fu M; Qi B; Han X; Zhou J; Ge J
    Int J Cardiovasc Imaging; 2020 Apr; 36(4):671-689. PubMed ID: 31893323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological validation of cardiac magnetic resonance T
    Zeng M; Zhang N; He Y; Wen Z; Wang Z; Zhao Y; Greiser A; An J; Zhang T; Jing B; Zhang X; Fan Z; Li D
    J Magn Reson Imaging; 2016 Nov; 44(5):1179-1185. PubMed ID: 27061226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
    Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal myocardial native T
    Burkhardt BEU; Menghini C; Rücker B; Kellenberger CJ; Valsangiacomo Buechel ER
    J Magn Reson Imaging; 2020 Mar; 51(3):897-903. PubMed ID: 31507010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.
    Dabir D; Child N; Kalra A; Rogers T; Gebker R; Jabbour A; Plein S; Yu CY; Otton J; Kidambi A; McDiarmid A; Broadbent D; Higgins DM; Schnackenburg B; Foote L; Cummins C; Nagel E; Puntmann VO
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):69. PubMed ID: 25384607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.